Welcome to our dedicated page for RYAN SPECIALTY HOLDINGS SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RYAN SPECIALTY HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RYAN SPECIALTY HOLDINGS's regulatory disclosures and financial reporting.
RYAN Specialty Holdings, Inc. reported that Co-President and CRO Brendan Martin Mulshine acquired a grant of 24,869 Restricted Stock Units on March 3, 2026. Each RSU represents a contingent right to receive one share of Class A common stock, vesting in three equal annual installments beginning on April 1, 2029.
Hamilton Janice M reported acquisition or exercise transactions in this Form 4 filing.
RYAN Specialty Holdings, Inc. Chief Financial Officer Janice M. Hamilton reported receiving a grant of 29,843 Restricted Stock Units on March 3, 2026. Each Restricted Stock Unit represents a contingent right to receive one share of the company’s Class A common stock upon vesting.
The Restricted Stock Units vest in three equal annual installments beginning on April 1, 2029. Following this award, Hamilton held 29,843 Restricted Stock Units as of the transaction date, all reported as directly owned.
Wuller Benjamin MIles reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings CEO Benjamin Miles Wuller reported an equity award of 24,869 Restricted Stock Units. Each unit represents a contingent right to receive one share of Class A common stock upon vesting. These RSUs vest in three equal annual installments beginning on April 1, 2029, and are held directly.
Ryan Specialty Holdings, Inc. reported that EVP & CHRO Michael Conklin acquired 24,869 Restricted Stock Units as a grant. Each unit represents a contingent right to receive one share of Class A common stock on vesting. The Restricted Stock Units vest in three equal annual installments beginning on April 1, 2029.
KATZ MARK STEPHEN reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings, Inc. granted Executive Vice President and General Counsel Mark Stephen Katz 24,869 Restricted Stock Units on March 3, 2026. The award was recorded at a price of $0.0000 per unit, reflecting its nature as an equity compensation grant rather than a cash purchase.
Each Restricted Stock Unit represents a contingent right to receive one share of Ryan Specialty Class A common stock upon vesting. According to the filing, these RSUs vest in three equal annual installments beginning on April 1, 2029, aligning Mr. Katz’s compensation with long-term shareholder interests over a multi-year period.
Ryan Specialty Holdings director Ryan Patrick G Jr reported open-market purchases of a total of 25,865 shares of Class A Common Stock. On February 23, 2026, trusts for the benefit of him and/or his family bought 24,000 shares at $39.94 and 1,500 shares at $40.20 per share, with 428,295 shares held indirectly afterward. On February 20, 2026, he directly purchased 365 shares at $41.41 per share, bringing his direct holdings to 256,559.053 shares. The trust-held shares are owned by trusts for which he is trustee, and he disclaims beneficial ownership except to the extent of his pecuniary interest.
T. Rowe Price Investment Management, Inc. reported beneficial ownership of 7,552,002 shares of Ryan Specialty Holdings common stock, representing 5.9% of the outstanding class as of the event date.
The firm reports sole voting power over 7,182,749 shares and sole dispositive power over 7,552,002 shares, with no shared voting or dispositive authority. It states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ryan Specialty Holdings.
Ryan Specialty Holdings files its annual report describing a fast-growing specialty insurance intermediary focused on the excess and surplus (E&S) market. For 2025, revenue rose 21.3%, driven by Wholesale Brokerage, Binding Authority, and Underwriting Management operations.
Wholesale Brokerage generated $1,600.4 million in net commissions and fees, Binding Authority $370.2 million, and Underwriting Management $1,024.0 million. Diluted earnings per share were $0.47 versus $0.71 in 2024, while Adjusted diluted EPS increased from $1.79 to $1.96, reflecting strong underlying performance despite higher investments and non‑GAAP adjustments.
The company emphasizes its leadership in the E&S market, where 78% of 2025 premiums were placed, and highlights consolidation among retail brokers and carriers as a tailwind. It reports strategic acquisitions in 2025, expanded international MGAs/MGUs, and ongoing investments in technology, including generative AI and the RT Connector digital marketplace, to support scalability and innovation.
Ryan Specialty Holdings reported strong 2025 growth but softer profitability, and announced several major capital actions. Full-year 2025 revenue rose 21.3% to $3.05 billion, with organic revenue growth of 10.1%. Adjusted EBITDAC increased 19.2% to $966.7 million, while net income declined 6.9% to $214.2 million.
In the fourth quarter, revenue grew 13.2% to $751.2 million, but net income fell 26.6% to $31.2 million as operating expenses and interest costs increased, compressing net income margin to 4.2%. Adjusted EBITDAC for the quarter rose 2.9% to $222.3 million, and adjusted diluted EPS held flat at $0.45.
The board approved a three-year “Empower Program” restructuring, expected to incur about $160 million of pre-tax charges through 2028 and generate roughly $80 million of annual savings in 2029. The board also authorized a share repurchase program of up to $300 million of Class A stock and raised the regular quarterly dividend by 8.3% to $0.13 per share, payable March 10, 2026 to holders of record on February 24, 2026.
Ryan Specialty Holdings, Inc. has scheduled its 2026 annual meeting of stockholders for April 28, 2026, to be held virtually by remote communication. Stockholders of record at the close of business on March 2, 2026 will be entitled to receive notice of and vote at the meeting.
The company set a February 22, 2026 deadline for stockholder proposals seeking inclusion in its proxy materials under SEC Rule 14a-8. For other proposals or director nominations under the company’s bylaws, written notice must be received by February 20, 2026 and comply with the bylaw and Rule 14a-19 requirements.